High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers

High incidence of germlineBRCAmutation in patients with ER low-positive/PR low-positive/HER-2neunegative tumors

(2015) Rachel A. Sanford et al.   CANCER

Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer

(2014) K. Hashimoto et al.   ANNALS OF ONCOLOGY

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations

(2014) V Secq et al.   BRITISH JOURNAL OF CANCER

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer

(2014) Heae Surng Park et al.   MODERN PATHOLOGY

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer

(2013) Mevlude Inanc et al.   MEDICAL ONCOLOGY

Analysis of PIK3CA Mutations in Breast Cancer Subtypes

(2013) Ruza Arsenic et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful

(2012) Maialen Martin-Arruti et al.   HISTOPATHOLOGY

Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer

(2012) Jabed Iqbal et al.   HISTOPATHOLOGY

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

(2011) A. M. Gonzalez-Angulo et al.   MOLECULAR CANCER THERAPEUTICS

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

(2010) Eun Yoon Cho et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

EGFR expression and gene copy number in triple-negative breast carcinoma

(2010) Berrak Gumuskaya et al.   CANCER GENETICS AND CYTOGENETICS

Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer

(2010) Monika L. Burness et al.   CANCER JOURNAL

PIK3CA Mutation Associates with Improved Outcome in Breast Cancer

(2009) K. Kalinsky et al.   CLINICAL CANCER RESEARCH

Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer

(2009) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

(2009) Elena López-Knowles et al.   INTERNATIONAL JOURNAL OF CANCER

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

(2008) M. Schmidt et al.   ANNALS OF ONCOLOGY

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

(2008) Tatsuya Toyama et al.   BMC CANCER

Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

(2008) Giuseppe Viale et al.   BREAST CANCER RESEARCH AND TREATMENT

An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

(2008) K. Stemke-Hale et al.   CANCER RESEARCH

EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy

(2008) Fernanda Milanezi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Helical domain and kinase domain mutations in p110  of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

(2008) L. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA